Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/34733
Type
ArticleCopyright
Open access
Embargo date
2020-08-12
Collections
- INI - Artigos de Periódicos [3646]
Metadata
Show full item record83
CITATIONS
83
Total citations
19
Recent citations
15
Field Citation Ratio
2.02
Relative Citation Ratio
SEPSIS-ASSOCIATED OUTCOMES IN CRITICALLY ILL PATIENTS WITH MALIGNANCIES
Author
Affilliation
Universidade Federal do Rio de Janeiro. School of Medicine. Postgraduate Program in Internal Medicine. Rio de Janeiro, RJ, Brazil.
National Cancer Institute. Postgraduate Program. Rio de Janeiro, RJ, Brazil / Hospital Sírio-Libanês. Research and Education Institute. São Paulo, SP, Brazil.
Pio XII Foundation. Hospital do Câncer de Barretos. ICU. Barretos, SP, Brazil.
A.C. Camargo Cancer Center. ICU. São Paulo, SP, Brazil.
Irmandade da Santa Casa de Misericórdia de Porto Alegre. Rede Institucional de Pesquisa e Inovação em Medicina Intensiva. Porto Alegre, RS, Brasil.
Hospital Israelita Albert Einstein. ICU. São Paulo, SP, Brazil.
Hospital Mater Dei. ICU. Belo Horizonte, MG, Brazil.
Clinica São Vicente. ICU. Rio de Janeiro, RJ, Brazil.
Hospital de Clinicas de Niteroi. ICU. Niteroi, RJ, Brazil.
Universidade Federal de Pernambuco. Hospital de Clinicas. Recife, PE, Brazil.
Hospital São Domingos-São Luís. ICU. São Luís, MA, Brazil.
Universidade Federal do Rio de Janeiro. School of Medicine. Postgraduate Program in Internal Medicine. Rio de Janeiro, RJ, Brazil.
D’Or Institute for Research and Education. Rio de Janeiro, RJ, Brazil / Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.
Universidade Federal do Rio de Janeiro. School of Medicine. Postgraduate Program in Internal Medicine. Rio de Janeiro, RJ, Brazil / National Cancer Institute. Postgraduate Program. Rio de Janeiro, RJ, Brazil / D’Or Institute for Research and Education. Rio de Janeiro, RJ, Brazil.
Universidade Federal do Rio de Janeiro. School of Medicine. Postgraduate Program in Internal Medicine. Rio de Janeiro, RJ, Brazil / National Cancer Institute. Postgraduate Program. Rio de Janeiro, RJ, Brazil / D’Or Institute for Research and Education. Rio de Janeiro, RJ, Brazil.
National Cancer Institute. Postgraduate Program. Rio de Janeiro, RJ, Brazil / Hospital Sírio-Libanês. Research and Education Institute. São Paulo, SP, Brazil.
Pio XII Foundation. Hospital do Câncer de Barretos. ICU. Barretos, SP, Brazil.
A.C. Camargo Cancer Center. ICU. São Paulo, SP, Brazil.
Irmandade da Santa Casa de Misericórdia de Porto Alegre. Rede Institucional de Pesquisa e Inovação em Medicina Intensiva. Porto Alegre, RS, Brasil.
Hospital Israelita Albert Einstein. ICU. São Paulo, SP, Brazil.
Hospital Mater Dei. ICU. Belo Horizonte, MG, Brazil.
Clinica São Vicente. ICU. Rio de Janeiro, RJ, Brazil.
Hospital de Clinicas de Niteroi. ICU. Niteroi, RJ, Brazil.
Universidade Federal de Pernambuco. Hospital de Clinicas. Recife, PE, Brazil.
Hospital São Domingos-São Luís. ICU. São Luís, MA, Brazil.
Universidade Federal do Rio de Janeiro. School of Medicine. Postgraduate Program in Internal Medicine. Rio de Janeiro, RJ, Brazil.
D’Or Institute for Research and Education. Rio de Janeiro, RJ, Brazil / Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.
Universidade Federal do Rio de Janeiro. School of Medicine. Postgraduate Program in Internal Medicine. Rio de Janeiro, RJ, Brazil / National Cancer Institute. Postgraduate Program. Rio de Janeiro, RJ, Brazil / D’Or Institute for Research and Education. Rio de Janeiro, RJ, Brazil.
Universidade Federal do Rio de Janeiro. School of Medicine. Postgraduate Program in Internal Medicine. Rio de Janeiro, RJ, Brazil / National Cancer Institute. Postgraduate Program. Rio de Janeiro, RJ, Brazil / D’Or Institute for Research and Education. Rio de Janeiro, RJ, Brazil.
Abstract
Rationale: Sepsis is a major cause of mortality among critically ill patients with cancer. Information about clinical outcomes and factors associated with increased risk of death in these patients is necessary to help physicians recognize those patients who are most likely to benefit from ICU therapy and identify possible targets for intervention. Objectives: In this study, we evaluated cancer patients with sepsis chosen from a multicenter prospective study to characterize their clinical characteristics and to identify independent risk factors associated with hospital mortality. Methods: Subgroup analysis of a multicenter prospective cohort study conducted in 28 Brazilian intensive care units (ICUs) to evaluate adult cancer patients with severe sepsis and septic shock. We used logistic regression to identify variables associated with hospital mortality. Measurements and Main Results: Of the 717 patients admitted to the participating ICUs, 268 (37%) had severe sepsis (n = 142, 53%) or septic shock (n = 126, 47%). These patients comprised the population of the present study. The mean score on the third version of the Simplified Acute Physiology Score was 62.9 6 17.7 points, and the median Sequential Organ Failure Assessment score was 9 (7–12) points. The most frequent sites of infection were the lungs (48%), intraabdominal region (25%), bloodstream as primary infection (19%), and urinary tract (17%). Half of the patients had microbiologically proven infections, and Gram-negative bacteria were the most common pathogens causing sepsis (31%). ICU and hospital mortality rates were 42% and 56%, respectively. In multivariable analysis, the number of acute organ dysfunctions (odds ratio [OR], 1.48; 95% confidence interval [CI], 1.16–1.87), hematological malignancies (OR, 2.57; 95% CI, 1.05–6.27), performance status 2–4 (OR, 2.53; 95% CI, 1.44–4.43), and polymicrobial infections (OR, 3.74; 95% CI, 1.52–9.21) were associated with hospital mortality. Conclusions: Sepsis is a common cause of critical illness in patients with cancer and remains associated with high mortality. Variables related to underlying malignancy, sepsis severity, and characteristics of infection are associated with a grim prognosis.
Share